Email this article Risk factors for recurrence in patients with virilizing ovarian tumors
- Authors: Cherepanova E.V.1, Laktionov K.P.1, Anurova O.A.1
-
Affiliations:
- N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
- Issue: No 3-4 (2012)
- Pages: 99-101
- Section: GYNECOLOGY. DIAGNOSIS
- Published: 24.09.2012
- URL: https://ojrs.abvpress.ru/ojrs/article/view/122
- DOI: https://doi.org/10.17650/1994-4098-2012-0-3-4-99-101
- ID: 122
Cite item
Full Text
Abstract
The paper presents the clinical, morphological, and immunohistochemical characteristics of virilizing ovarian tumors in 53 patients treated at the N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, from 1967 to 2010. The impact of the immu- nophenotype of virilizing ovarian tumor cells, clinical and morphological parameters, and performed treatment on the risk of recurrence has been studied in patients with virilizing ovarian tumors.
About the authors
E. V. Cherepanova
N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Author for correspondence.
Email: katerinochka-k@rambler.ru
Russian Federation
K. P. Laktionov
N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, MoscowRussian Federation
O. A. Anurova
N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, MoscowRussian Federation
References
Supplementary files
